Improving risk assessment
- PMID: 23136041
- DOI: 10.1126/scitranslmed.3003497
Improving risk assessment
Abstract
Widespread sharing and analysis of clinical trial data and a U.S. government initiative to engineer nonclinical cell-based models that mimic human biological processes have the potential to improve predictions of drug-related adverse events.
MeSH terms
LinkOut - more resources
Full Text Sources